Protalix Biotherapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protalix Biotherapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.0M | 464k | 2.22 |
| 2025-06-30 | $718k | 485k | 1.48 |
| 2024-03-31 | $416k | 330k | 1.26 |
| 2023-12-31 | $539k | 303k | 1.78 |
| 2023-09-30 | $467k | 281k | 1.66 |
| 2023-06-30 | $461k | 230k | 2.00 |